| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/14/2006 | WO2006095159A1 (imidazolo-5-yl)-2-anilo-pyrimidines as agents for the inhibition of cell proliferation |
| 09/14/2006 | WO2006095014A1 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/14/2006 | WO2006095009A1 Amido-substituted 6-phenylphenanthridines |
| 09/14/2006 | WO2006094904A1 Process for the preparation of optically active derivatives of 2-(2-pyridylmethylsulfinyl)-benzimidazole via inclusion complex with 1,1'-binaphthalene-2, 2'diol |
| 09/14/2006 | WO2006094799A2 Pyridinone derivatives against malaria |
| 09/14/2006 | WO2006094763A1 3,4,5-substituted piperidine compounds |
| 09/14/2006 | WO2006094691A1 PYRAZINE -2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS |
| 09/14/2006 | WO2006094639A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | WO2006094395A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions |
| 09/14/2006 | WO2006074269A3 Preparation of pharmaceutical salts of piperazine compounds |
| 09/14/2006 | WO2006067445A3 Csf-1r kinase inhibitors |
| 09/14/2006 | WO2006051290A3 Compounds for treating protein-kinase mediated disorders |
| 09/14/2006 | WO2006040113A3 Heterocyclic diamide insecticidal agents |
| 09/14/2006 | WO2004073634A3 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 09/14/2006 | US20060205949 Crystalline forms of a biphenyl compound |
| 09/14/2006 | US20060205945 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/14/2006 | US20060205942 2-(2-Hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 09/14/2006 | US20060205786 New use of iloperidone |
| 09/14/2006 | US20060205785 Fused ring compounds substituted with a 8-azabicyclo[3.2.1]octane(cyclo)alkylene group, including benzothiazolones, e.g., 3-[3-(3-Propyl-8-aza-bicyclo[3.2.1]oct-8-yl)-propyl]-3H-benzothiazol-2-one; highly selective muscarinic agonists, particularly for the M1 and/or M4 receptor subtypes |
| 09/14/2006 | US20060205784 Biphenyl compounds useful as muscarinic receptor antagonists |
| 09/14/2006 | US20060205783 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 09/14/2006 | US20060205775 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; e.g. biphenyl-2-ylcarbamic acid 1-[2-((4-[4-(2-hydroxyethylcarbamoyl)piperidin-1-ylmethyl]benzoyl)methylamino)ethyl]piperidin-4-yl ester |
| 09/14/2006 | US20060205774 4-(4-(Heterocyclylakoxy) phenyl-1-(heterocyclyl-carbonyl) piperidine derivavites and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
| 09/14/2006 | US20060205769 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 09/14/2006 | US20060205755 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 09/14/2006 | US20060205740 Chemical compounds |
| 09/14/2006 | US20060205735 Quinoline-4-carboxamide as NK-2 and NK-3 receptor antagonists |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205732 Nonphytotoxic; 4-Bromo-3-methoxy-N-4-[4(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide; 4-[(Allyloxycarbonyl)amino]-3-methoxy-N-4-[4-(trifluoromethyl)phenoxy]phenyl-thiophene-2-carboxamide |
| 09/14/2006 | US20060205722 Such as N-{1-[2-(1,3-dioxan-2-yl)ethyl]piperidin-4-yl}-N-(4-fluorobenzyl)-2-[4-(2-hydroxy-2-methylpropoxy)phenyl]acetamide; selective inverse agonists of 5-HT2A receptor with minimal monamine receptors subtype activity; antipsychotics with reduced side effects |
| 09/14/2006 | US20060205715 6-(8-Pentylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy)-nicotinamide; increase metabolic energy consumption, and reduction of weight; obesity, antidiabetic agent, eating disorders; antidepressant, anxiolytic agent |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060205708 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | US20060205675 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus |
| 09/14/2006 | CA2600367A1 Process for preparing macrocyclic compounds |
| 09/14/2006 | CA2600169A1 Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | CA2599974A1 Pyridine-2-carboxamide derivatives as mglur5 antagonists |
| 09/14/2006 | CA2599511A1 2-(4-oxo-4h-quinazolin-3-yl) acetamides and their use as vasopressin v3 antagonists |
| 09/14/2006 | CA2599368A1 Amido-substituted 6-phenylphenanthridines |
| 09/14/2006 | CA2598861A1 Organic compounds |
| 09/13/2006 | EP1700850A1 Novel phenylalanine derivative |
| 09/13/2006 | EP1700845A1 Insecticidal anthranilamides |
| 09/13/2006 | EP1699783A1 Opioid receptor antagonists |
| 09/13/2006 | EP1699781A1 1-acetic acid-indole, -indazole and -benzimidazole derivatives useful for the treatment of respiratory disorders |
| 09/13/2006 | EP1699780A1 Novel quinoline derivatives |
| 09/13/2006 | EP1699779A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 09/13/2006 | EP1699778A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 09/13/2006 | EP1699777A1 Dipeptidyl peptidase inhibitors |
| 09/13/2006 | EP1699762A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension |
| 09/13/2006 | EP1699761A1 Cb1 modulator compounds |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP1699454A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 09/13/2006 | EP1699421A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 09/13/2006 | EP1487424B1 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases |
| 09/13/2006 | EP1483257B1 Quinazoline compounds useful in therapy |
| 09/13/2006 | EP1412364B1 Platelet adp receptor inhibitors |
| 09/13/2006 | EP1237888B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1082319B1 Benzocarbazole and indenoindole derived estrogenic agents |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1833470A Compound, charge transporting material and organic electroluminescent element |
| 09/13/2006 | CN1832945A Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 09/13/2006 | CN1832940A Substituted indazolyl(indolyl)maleimide derivatives as kinase inhibitors |
| 09/13/2006 | CN1832937A Tacrine derivatives as inhibitors of acetylcholinesterase |
| 09/13/2006 | CN1832936A Processes for the preparation of n-((((pyridinyloxy)-phenylamino)quinazolinyl)-allyl)acetamide derivatives and related compounds as well as intermediates of such processes and processes for the prepar |
| 09/13/2006 | CN1832935A Therapeutic agents useful for treating pain |
| 09/13/2006 | CN1832929A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/13/2006 | CN1832928A 5-membered heterocycle-based p38 kinase inhibitors |
| 09/13/2006 | CN1832927A Novel gamma-secretase inhibitors |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1832921A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 09/13/2006 | CN1832745A 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 09/13/2006 | CN1832744A Treatment for alzheimer's disease and related conditions |
| 09/13/2006 | CN1832740A Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1274685C Benzimidazol derivatives modulate che mokine receptors |
| 09/13/2006 | CN1274676C Quinoline and quinazoline derivatives |
| 09/13/2006 | CN1274675C Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105681 Forming compounds with oxidation using hydrogen peroxide to form sulfur oxide for antisecretory agents of gastric juice |
| 09/12/2006 | US7105669 Quinazoline derivatives |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105567 Such as N-benzyl-N'-(2,6-dimethylphenyl)-N-(4-octylphenyl)urea for treating autoimmune diseases, sepsis, adult respiratory distress syndrome, chronic obstructive pulmonary disease, allergies/asthma, atherosclerosis, and brain disorders |
| 09/12/2006 | US7105563 5-ureido-3-[(4-(3-methoxyphenyl)pyrrol-2-yl)methylene]indolin-2-one and derivatives; inhibition of phosphoinositide-dependent kinase-1 (PDK-1). |
| 09/12/2006 | US7105559 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 09/12/2006 | US7105549 Aryl substituted pyridines and the use thereof |
| 09/12/2006 | US7105548 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
| 09/12/2006 | US7105546 Useful for treating or preventing neuronal damage associated with neurological diseases |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105543 4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/12/2006 | US7105533 3-(3-methoxy-4-(pyridin-2-yl)phenyl)imidazo[1,5-a]pyridine hydrochloride; mGluR5 modulators treating psychiatric and mood disorders, schizophrenia, anxiety, depression, panic, pain |
| 09/12/2006 | US7105531 Tricyclic protein kinase inhibitors |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105528 exhibit a surprising strong efficacy in lowering the intraocular pressure; excellent duration of action; excellent tolerability |
| 09/12/2006 | US7105522 Aids therapy; viricides |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |